A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Sign Up to like & getrecommendations! Published in 2023 at "Future oncology"
DOI: 10.2217/fon-2022-1149
Abstract: WHAT IS THIS SUMMARY ABOUT? This is a summary of the 1-year results of a clinical research study known as CheckMate 649 published in The Lancet in June 2021. The 2-year results on the participants'… read more here.
Keywords: checkmate 649; nivolumab chemotherapy; chemotherapy; treatment ... See more keywords
Neoadjuvant nivolumab with chemotherapy: A miraculous new regime in treatment of resectable lung cancers.
Sign Up to like & getrecommendations! Published in 2022 at "JPMA. The Journal of the Pakistan Medical Association"
DOI: 10.47391/jpma.6912
Abstract: Madam, lung cancer is one of the commonly diagnosed causes of cancer mortality and morbidity worldwide, accounting for approximately 1.76 million deaths annually.1 In the past overall survival in patients with non-small cell lung cancer… read more here.
Keywords: nivolumab chemotherapy; neoadjuvant nivolumab; chemotherapy alone; lung ... See more keywords